VFA
JAZZ icon

Valeo Financial Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Valeo Financial Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-12
Closed -$2K – 1177
2021
Q1 		$2K Buy
12
+2
+20% +$329 ﹤0.01% 1798
2020
Q4 		$2K Hold
10
– – ﹤0.01% 1522
2020
Q3 		$1K Sell
10
-63
-86% -$7.81K ﹤0.01% 1486
2020
Q2 		$8K Buy
73
+10
+16% +$1.11K ﹤0.01% 1356
2020
Q1 		$7K Hold
63
– – ﹤0.01% 1209
2019
Q4 		$9K Buy
63
+1
+2% +$136 ﹤0.01% 1140
2019
Q3 		$8K Hold
62
– – ﹤0.01% 1087
2019
Q2 		$9K Hold
62
– – ﹤0.01% 1053
2019
Q1 		$9K Buy
62
+7
+13% +$913 ﹤0.01% 996
2018
Q4 		$7K Sell
55
-28
-34% -$4.15K ﹤0.01% 978
2018
Q3 		$13K Buy
83
+28
+51% +$4.82K ﹤0.01% 892
2018
Q2 		$10K Hold
55
– – ﹤0.01% 940
2018
Q1 		$8K Hold
55
– – ﹤0.01% 991
2017
Q4 		$7K Sell
55
-8
-13% -$1.11K ﹤0.01% 913
2017
Q3 		$9K Buy
+63
New +$9.53K ﹤0.01% 728

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Valeo Financial Advisors's JAZZ Position: Q2 2021 in Review

Valeo Financial Advisors sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2021, closing a stake of 12 shares — an estimated $2K sold.

Valeo Financial Advisors first reported a position in JAZZ in Q3 2017 and held it in 15 quarters. The position peaked at $13K in Q3 2018. 505 funds tracked by Wall St. Rank hold JAZZ as of Q2 2021.

  • Valeo Financial Advisors reported no remaining Jazz Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Valeo Financial Advisors sold 12 Jazz Pharmaceuticals shares in Q2 2021, an estimated $2K.
  • Valeo Financial Advisors first reported a position in Jazz Pharmaceuticals in Q3 2017 and held it in 15 quarters.
  • Valeo Financial Advisors's Jazz Pharmaceuticals position peaked at $13K in Q3 2018.
  • 505 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2021.

Based on Valeo Financial Advisors's 13F filing for Q2 2021, filed 22 Jul 2021.